Abstract
Background/Objectives: To describe SARS-CoV-2 positivity, temporal patterns, and associated factors among pregnant and postpartum women hospitalized with acute respiratory infection or febrile illness (ARFI) in Suzhou, China. Methods: Women who met the ARFI case definition between 2020 and 2024 were included and tested for SARS-CoV-2. Epidemiological and clinical characteristics, disease severity, and outcomes were compared between SARS-CoV-2-positive and non-SARS-CoV-2 ARFI cases. Multivariable logistic regression was used to identify factors associated with SARS-CoV-2 positivity. Results: Among 4219 pregnant and postpartum women hospitalized with ARFI and enrolled in surveillance, 512 (12.1%) tested positive for SARS-CoV-2. After excluding six women with influenza coinfection, the analytic cohort included 512 women who tested positive and 3701 who tested negative. SARS-CoV-2 positivity peaked in December 2022, May–June 2023, and July–August 2024. Among women admitted from December 2022 through December 2024, gestational diabetes mellitus was associated with higher odds of SARS-CoV-2 positivity after adjustment for admission year, vaccination status before admission, and other covariates (aOR 2.21, 95% CI 1.57–3.10). Conclusions: Among pregnant and postpartum women hospitalized with ARFI, gestational diabetes mellitus (GDM) was associated with higher odds of SARS-CoV-2 positivity. These findings support continued active surveillance for respiratory viral infections in this population during the post-emergency phase, with particular attention to women with GDM.